BioNexus Gene Lab Corp (BGLC) has 5 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 14, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 14, 2026 filed Aug. 13, 2026 | Tan Lee Su-Leng Chief Executive Officer | $0 | 338,709 | New | No | |
|
|
||||||
| Aug. 14, 2026 filed Aug. 13, 2026 | Bin Abdul Hamid Muhammad Azrul Director | $0 | 32,258 | New | No | |
|
|
||||||
| Aug. 14, 2026 filed Aug. 13, 2026 | Yap Chee Keong Director | $0 | 32,258 | New | No | |
|
|
||||||
| Aug. 14, 2026 filed Aug. 13, 2026 | Chong Set Fui Chief Financial Officer | $0 | 96,774 | New | No | |
|
|
||||||
| Aug. 14, 2026 filed Aug. 13, 2026 | Low Jook Yuen Director | $0 | 16,129 | +1279% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free